{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:09:31Z","timestamp":1777860571746,"version":"3.51.4"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.imlet.2024.106840","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T21:36:02Z","timestamp":1706823362000},"page":"106840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["IL-38 in Beh\u00e7et's disease: Gene expression in bronchoalveolar lavage from patients having pulmonary involvement"],"prefix":"10.1016","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9149-6934","authenticated-orcid":false,"given":"Kamel","family":"Hamzaoui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrine","family":"Louhaichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariem","family":"Salhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fay\u00e7al Haj","family":"Sassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Laathar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Hamzaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2024.106840_bib0001","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaut.2014.01.014","article-title":"Criteria for Beh\u00e7et's disease with reflections on all disease criteria","volume":"48-49","author":"Yazici","year":"2014","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.imlet.2024.106840_bib0002","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/annrheumdis-2018-213225","article-title":"2018 update of the EULAR recommendations for the management of Beh\u00e7et's syndrome","volume":"77","author":"Hatemi","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2024.106840_bib0003","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12016-012-8319-x","article-title":"Beh\u00e7et syndrome: is it one condition?","volume":"43","author":"Yazici","year":"2012","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2024.106840_bib0004","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41584-022-00880-7","article-title":"Vascular Beh\u00e7et syndrome: from pathogenesis to treatment","volume":"19","author":"Bettiol","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"issue":"7","key":"10.1016\/j.imlet.2024.106840_bib0005","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/thorax.56.7.572","article-title":"Pulmonary manifestations of Beh\u00e7et's disease","volume":"56","author":"Erkan","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.imlet.2024.106840_bib0006","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.rmr.2022.04.010","article-title":"Atteintes thoraciques de la maladie de Beh\u00e7et [Thoracic manifestations of Behcet's disease]","volume":"39","author":"Ghembaza","year":"2022","journal-title":"Rev. Mal. Respir."},{"issue":"2","key":"10.1016\/j.imlet.2024.106840_bib0007","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nrrheum.2017.208","article-title":"Beh\u00e7et syndrome: a contemporary view","volume":"14","author":"Yazici","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1061","key":"10.1016\/j.imlet.2024.106840_bib0008","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150992","article-title":"The lung in systemic vasculitis: radiological patterns and differential diagnosis","volume":"89","author":"Feragalli","year":"2016","journal-title":"Br. J. Radiol."},{"issue":"5","key":"10.1016\/j.imlet.2024.106840_bib0009","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s11739-018-1991-y","article-title":"Vascular Beh\u00e7et's syndrome: an update","volume":"14","author":"Emmi G","year":"2019","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.imlet.2024.106840_bib0010","first-page":"S54","article-title":"Pulmonary artery aneurysms in Beh\u00e7et's syndrome: a review of the literature with emphasis on geographical differences","volume":"33","author":"Celik","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.imlet.2024.106840_bib0011","first-page":"35","article-title":"Pulmonary artery involvement and associated lung disease in Beh\u00e7et disease: a series of 47 patients","volume":"201291","author":"Hamuryudan","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.imlet.2024.106840_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.151956","article-title":"Immunopathogenesis of Beh\u00e7et's disease and treatment modalities","volume":"52","author":"van der Houwen","year":"2022","journal-title":"Semin. Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.imlet.2024.106840_bib0013","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/intimm\/dxt046","article-title":"Novel NLRP3\/cryopyrin mutations and pro-inflammatory cytokine profiles in Beh\u00e7et's syndrome patients","volume":"26","author":"Y\u00fcksel","year":"2014","journal-title":"Int. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2024.106840_bib0014","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.21873\/invivo.11629","article-title":"Enhanced NLRP3 and DEFA1B expression during the active stage of parenchymal Neuro-Beh\u00e7et's disease","volume":"33","author":"Ugurel","year":"2019","journal-title":"In Vivo (Brooklyn)"},{"key":"10.1016\/j.imlet.2024.106840_bib0015","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.3390\/ijms21062144","article-title":"Modulation of NLRP3 inflammasome through formyl peptide receptor 1 (Fpr-1) pathway as a new therapeutic target in bronchiolitis obliterans syndrome","volume":"21","author":"D'Amico","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.imlet.2024.106840_bib0016","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.intimp.2014.12.009","article-title":"Asiatic acid ameliorates dextran sulfate sodium-induced murine experimental colitis via suppressing mitochondria mediated NLRP3 inflammasome activation","volume":"24","author":"Guo","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.imlet.2024.106840_bib0017","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/jcp.30948","article-title":"Potential roles of NLRP3 inflammasome in the pathogenesis of Kawasaki disease","volume":"238","author":"Shahi","year":"2023","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.imlet.2024.106840_bib0018","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/030097402320318387","article-title":"Cytokine profile in Beh\u00e7et's disease patients. Relationship with disease activity","volume":"31","author":"Hamzaoui","year":"2002","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.imlet.2024.106840_bib0019","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.imlet.2016.12.001","article-title":"An elevated pro-inflammatory cytokines profile in Behcet's disease: a multiplex analysis","volume":"186","author":"Gholijani","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.imlet.2024.106840_bib0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12950-015-0086-z","article-title":"Increased expression of the NLRP3 inflammasome components in patients with Behc\u00b8et's disease","volume":"12","author":"Kim","year":"2015","journal-title":"J. Inflamm. (Lond)"},{"issue":"1","key":"10.1016\/j.imlet.2024.106840_bib0021","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-9255-9-3","article-title":"NOD2 is highly expressed in Beh\u00e7et disease with pulmonary manifestations","volume":"9","author":"Hamzaoui","year":"2012","journal-title":"J. Inflamm. (Lond)"},{"issue":"6","key":"10.1016\/j.imlet.2024.106840_bib0022","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/13816810.2021.1955273","article-title":"Association of NOD1, NOD2, PYDC1 and PYDC2 genes with Behcet's disease susceptibility and clinical manifestations","volume":"42","author":"Kocaaga","year":"2021","journal-title":"Ophthalmic Genet."},{"issue":"3","key":"10.1016\/j.imlet.2024.106840_bib0023","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1684\/ecn.2019.0430","article-title":"IL-38 serum levels in patients with Behcet's disease and the relationship with clinical features","volume":"30","author":"Zarrabi","year":"2019","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.imlet.2024.106840_bib0024","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1006\/geno.2002.6751","article-title":"Sequence-based map of the nine genes of the human interleukin-1 cluster","volume":"79","author":"Nicklin","year":"2002","journal-title":"Genomics"},{"key":"10.1016\/j.imlet.2024.106840_bib0025","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/CIRCULATIONAHA.110.948570","article-title":"Meta-analysis of genome-wide association studies in >80,000 subjects identify multiple loci for C-reactive protein levels","volume":"123","author":"Dehghan","year":"2011","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.imlet.2024.106840_bib0026","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3390\/biom9080345","article-title":"IL-38: a new player in inflammatory autoimmune disorders","volume":"9","author":"Xie","year":"2019","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.imlet.2024.106840_bib0027","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/BOR.0000000000000361","article-title":"The novel interleukin-1 cytokine family members in inflammatory diseases","volume":"29","author":"Hahn","year":"2017","journal-title":"Curr. Opin. Rheumatol."},{"issue":"8","key":"10.1016\/j.imlet.2024.106840_bib0028","doi-asserted-by":"crossref","first-page":"e991","DOI":"10.1002\/iid3.991","article-title":"The emerging role of IL-38 in diseases: a comprehensive review","volume":"11","author":"Chen","year":"2023","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.imlet.2024.106840_bib0029","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/jmcb\/mjw006","article-title":"Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses","volume":"8","author":"Mora","year":"2016","journal-title":"J. Mol. Cell Boil."},{"issue":"7","key":"10.1016\/j.imlet.2024.106840_bib0030","doi-asserted-by":"crossref","first-page":"e67650","DOI":"10.1371\/journal.pone.0067650","article-title":"Are C-reactive protein associated genetic variants associated with serum levels and retinal markers of microvascular pathology in Asian populations from Singapore?","volume":"8","author":"Dorajoo","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.imlet.2024.106840_bib0031","first-page":"1078","article-title":"Criteria for diagnosis of Behcet's disease, International study group for Behcet's disease","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2024.106840_bib0032","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/rheumatology\/38.8.728","article-title":"Beh\u00e7et's disease: evaluation of a new instrument to measure clinical activity","volume":"38","author":"Bhakta","year":"1999","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.imlet.2024.106840_bib0033","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/rheumatology\/keg453","article-title":"The Behcet's disease activity index","volume":"43","author":"Lawton","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.imlet.2024.106840_bib0034","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.imlet.2024.106840_bib0035","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.imlet.2024.106840_bib0036","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.imlet.2019.05.004","article-title":"Th 9 cells in Beh\u00e7et disease: possible involvement of IL-9 in pulmonary manifestations","volume":"211","author":"Khaouthar","year":"2019","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.imlet.2024.106840_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2022.577820","article-title":"Elevated levels of IL-32 in cerebrospinal fluid of neuro-Behcet disease: correlation with NLRP3 inflammasome","volume":"365","author":"Hamzaoui","year":"2022","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.imlet.2024.106840_bib0038","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.imlet.2015.08.001","article-title":"Interleukin-37 expression is decreased in Beh\u00e7et's disease and is associated with inflammation","volume":"167","author":"Bouali","year":"2015","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.imlet.2024.106840_bib0039","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-007-8064-8","article-title":"The unique features of vasculitis in Behcet's syndrome","volume":"35","author":"Melikoglu","year":"2008","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2024.106840_bib0040","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.rdc.2023.03.010","article-title":"Beh\u00e7et syndrome","volume":"49","author":"Hatemi","year":"2023","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.imlet.2024.106840_bib0041","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.rmed.2018.11.003","article-title":"Pulmonary manifestations of large, medium, and variable vessel vasculitis","volume":"145","author":"Adams","year":"2018","journal-title":"Respir. Med."},{"issue":"5","key":"10.1016\/j.imlet.2024.106840_bib0042","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.resinv.2017.06.001","article-title":"Over expression of IL-38 protein in anti-cancer drug-induced lung injury and acute exacerbation of idiopathic pulmonary fibrosis","volume":"55","author":"Tominaga","year":"2017","journal-title":"Respir. Investig."},{"issue":"1","key":"10.1016\/j.imlet.2024.106840_bib0043","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41419-020-03283-2","article-title":"Interleukin-38ameliorates poly(I:C) induced lung inflammation: therapeutic implications in respiratory viral infections","volume":"12","author":"Gao","year":"2021","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.imlet.2024.106840_bib0044","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.3390\/ijms24065676","article-title":"Cell intrinsic IL-38 affects B cell differentiation and antibody production","volume":"24","author":"Huard","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.imlet.2024.106840_bib0045","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/cei.13664","article-title":"Neutrophil-mediated mechanisms of damage and in-vitro protective effect of colchicine in non-vascular Behcet's syndrome","volume":"206","author":"Bettiol","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imlet.2024.106840_bib0046","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1183\/09031936.00002314","article-title":"Interleukin-17 cytokine signalling in patients with asthma","volume":"44","author":"Lind\u00e9n","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.imlet.2024.106840_bib0047","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.4049\/jimmunol.1301538","article-title":"IL-17A promotes the exacerbation of IL-33-induced airway hyperresponsiveness by enhancing neutrophilic inflammation via CXCR2 signaling in mice","volume":"192","author":"Mizutani","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2024.106840_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102763","article-title":"Interleukin 1alpha: a comprehensive review on the role of IL-1alpha in the pathogenesis and treatment of autoimmune and inflammatory diseases","volume":"20","author":"Cavalli","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2024.106840_bib0049","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/CIRCRESAHA.107.161067","article-title":"Interleukin-1beta causes acute lung injury via alphavbeta5 and alphavbeta6 integrin\u2013 dependent mechanisms","volume":"102","author":"Ganter","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.imlet.2024.106840_bib0050","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1164\/ajrccm.153.6.8665045","article-title":"Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1","volume":"153","author":"Pugin","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.imlet.2024.106840_bib0051","doi-asserted-by":"crossref","first-page":"18579","DOI":"10.1074\/jbc.M410561200","article-title":"Interleukin-1beta decreases expression of the epithelial rcells via a p38 MAPK\u2013dependent signaling pathway","volume":"280","author":"Roux","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.imlet.2024.106840_bib0052","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/17843286.2017.1314241","article-title":"Investigating the role of IL-33 in the pathogenesis of Beh\u00e7et's disease","volume":"72","author":"\u00c7er\u00e7i","year":"2017","journal-title":"Acta Clin. Belg."},{"key":"10.1016\/j.imlet.2024.106840_bib0053","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1183\/09031936.00105013","article-title":"Elevated expression of the NLRP3 inflammasome in neutrophilic asthma","volume":"43","author":"Simpson","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.imlet.2024.106840_bib0054","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1002\/iid3.750","article-title":"The role of the NLRP3 inflammasome in chronic inflammation in asthma and chronic obstructive pulmonary disease","volume":"10","author":"Wu","year":"2022","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.imlet.2024.106840_bib0055","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12871-022-01874-4","article-title":"Aerobic exercise alleviates ventilator-induced lung injury by inhibiting NLRP3 inflammasome activation","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Anesthesiol."},{"key":"10.1016\/j.imlet.2024.106840_bib0056","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2024.106840_bib0057","doi-asserted-by":"crossref","first-page":"e22687","DOI":"10.1096\/fj.202201348R","article-title":"Possible role of the NLRP3 inflammasome and the gutbrain axis in multiple sclerosis-related depression","volume":"37","author":"Maciak","year":"2023","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.imlet.2024.106840_bib0058","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/cvr\/cvab010","article-title":"NLRP3 inflammasome as a key driver of vascular disease","volume":"118","author":"Takahashi","year":"2022","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.imlet.2024.106840_bib0059","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/BOR.0000000000000962","article-title":"Vasculitis and the NLRP3 inflammasome","volume":"36","author":"Hamzaoui","year":"2024","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.imlet.2024.106840_bib0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41927-020-00172-1","article-title":"Diagnosis of Behcet's disease: clinical characteristics, diagnostic criteria, and differential diagnoses","volume":"5","author":"Kiafar","year":"2021","journal-title":"BMC Rheumatol."},{"issue":"10","key":"10.1016\/j.imlet.2024.106840_bib0061","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/jir.2021.0047","article-title":"Interleukin-38 suppresses cell migration and proliferation and promotes apoptosis","volume":"41","author":"Huang","year":"2021","journal-title":"J. Interferon Cytokine Res."},{"issue":"10","key":"10.1016\/j.imlet.2024.106840_bib0062","first-page":"24","article-title":"Elevated plasma IL-38 concentrations in patients with acute ST-segment elevation myocardial infarction and their dynamics after reperfusion treatment","volume":"490120","author":"Zhong","year":"2015","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.imlet.2024.106840_bib0063","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s10753-022-01718-w","article-title":"The pathogenic role of oxidative stress, cytokine expression, and impaired hematological indices in diabetic cardiovascular diseases","volume":"46","author":"Saad","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.imlet.2024.106840_bib0064","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.imlet.2024.106840_bib0065","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.imlet.2011.10.005","article-title":"Intracellular detection of interleukin 17 and other cytokines in human bronchoalveolar lavage fluid: a first assessment","volume":"141","author":"De Luca","year":"2012","journal-title":"Immunol. Lett."},{"issue":"8","key":"10.1016\/j.imlet.2024.106840_bib0066","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.3390\/cells11081306","article-title":"B cells specific CpG induces high IL-10 and IL-6 expression in vitro in Neuro-Beh\u00e7et's disease","volume":"11","author":"Maghrebi","year":"2022","journal-title":"Cells."},{"issue":"13","key":"10.1016\/j.imlet.2024.106840_bib0067","article-title":"IL-10 revisited in systemic lupus erythematosus","volume":"1","author":"Biswas","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247824000129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247824000129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:43:01Z","timestamp":1759045381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247824000129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":67,"alternative-id":["S0165247824000129"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2024.106840","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-38 in Beh\u00e7et's disease: Gene expression in bronchoalveolar lavage from patients having pulmonary involvement","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2024.106840","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106840"}}